EBAMed Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
EBAMed General Information
Description
Developer of the next-generation radiation therapy technology designed to treat cardiac arrhythmias from outside the heart. The company's device utilizes proton therapy, capable of selectively treating the tissues responsible for heart arrhythmias, enabling patients to undergo a non-invasive treatment in a single outpatient session.
Contact Information
Website
www.eba-med.comCorporate Office
- Chemin des Mines 15
- 1202 Geneva
- Switzerland
Corporate Office
- Chemin des Mines 15
- 1202 Geneva
- Switzerland
EBAMed Timeline
EBAMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | 01-Feb-2026 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series B) | 23-Jun-2025 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series A) | 24-Jan-2025 | Completed | Generating Revenue | |||
| 10. Grant | 31-Aug-2023 | Completed | Generating Revenue | |||
| 9. Early Stage VC | 29-Jul-2021 | Completed | Generating Revenue | |||
| 8. Grant | 23-Sep-2020 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue | |||
| 6. Seed Round | 21-Aug-2019 | Completed | Generating Revenue | |||
| 5. Grant | 23-Jul-2019 | $56.4K | $181K | Completed | Generating Revenue | |
| 4. Accelerator/Incubator | 30-Oct-2018 | $80.5K | $181K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
EBAMed Patents
EBAMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1152035-S1 | Ultrasound probe assembly | Active | 27-Dec-2024 | ||
| EP-4580508-A1 | Ultrasound probe holding assembly | Pending | 29-Aug-2022 | ||
| US-20260023048-A1 | Ultrasound probe holding assembly | Pending | 29-Aug-2022 | ||
| WO-2024062307-A1 | Ultrasound probe holding assembly | Inactive | 29-Aug-2022 | ||
| EP-4267243-A1 | A multiplanar motion management system | Pending | 23-Dec-2020 | A61N5/1068 |
EBAMed Signals
EBAMed Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EFI Lake Geneva Ventures | Venture Capital | Minority | ||
| European Union | Government | Minority | ||
| LIFTT | Venture Capital | Minority | ||
| OCCIDENT () | Family Office | Minority | ||
| Panakes Partners | Venture Capital | Minority |
EBAMed FAQs
-
When was EBAMed founded?
EBAMed was founded in 2018.
-
Where is EBAMed headquartered?
EBAMed is headquartered in Geneva, Switzerland.
-
What is the size of EBAMed?
EBAMed has 18 total employees.
-
What industry is EBAMed in?
EBAMed’s primary industry is Diagnostic Equipment.
-
Is EBAMed a private or public company?
EBAMed is a Private company.
-
What is EBAMed’s current revenue?
The current revenue for EBAMed is .
-
How much funding has EBAMed raised over time?
EBAMed has raised $51.1M.
-
Who are EBAMed’s investors?
EFI Lake Geneva Ventures, European Union, LIFTT, OCCIDENT (), and Panakes Partners are 5 of 10 investors who have invested in EBAMed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process